共 274 条
[1]
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30
[2]
Miller KD(2010)Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research Cancer Treat Rev 36 206-215
[3]
Jemal A(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Investig 121 2750-2767
[4]
Bosch A(2016)Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease Nat Rev Clin Oncol 13 674-690
[5]
Eroles P(2015)Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome Hum Pathol 46 1267-1274
[6]
Zaragoza R(2021)Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix Cancers (Basel). 13 713-45
[7]
Vina JR(2016)EMT: 2016 Cell 166 21-226
[8]
Lluch A(2019)EMT transition states during tumor progression and metastasis Trends Cell Biol 29 212-403
[9]
Lehmann BD(2012)Cancer stem cells and epithelial–mesenchymal transition: concepts and molecular links Semin Cancer Biol 22 396-84
[10]
Bauer JA(2019)New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer Nat Rev Mol Cell Biol 20 69-715